NCT01439009View on ClinicalTrials.gov

Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Heart Failure
Interventions
DRUG

Tolvaptan

Once-daily oral administration of one tolvaptan 15 mg tablet in the morning

DRUG

Placebo of tolvaptan

Once-daily oral administration of one placebo tablet in the morning

Trial Locations (8)

Unknown

Chube Region

Chushikoku Region

Hokkaido Region

Hokuriku Region

Kansai Region

Kanto Region

Kyushu Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY